메뉴 건너뛰기




Volumn 24, Issue 2, 2012, Pages 77-83

Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression

Author keywords

Androgen receptors; Breast carcinoma; Estrogen receptors; Her2 neu; Progesterone receptors; Triple negative breast cancer

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

EID: 84862650921     PISSN: 11100362     EISSN: 16879996     Source Type: Journal    
DOI: 10.1016/j.jnci.2012.04.001     Document Type: Article
Times cited : (15)

References (23)
  • 1
    • 33846266252 scopus 로고    scopus 로고
    • Prognostic markers in triple-negative breast cancer
    • Rakha E., El-sayed M., Green A., et al. Prognostic markers in triple-negative breast cancer. Cancer 2007, 109:25-32.
    • (2007) Cancer , vol.109 , pp. 25-32
    • Rakha, E.1    El-sayed, M.2    Green, A.3
  • 2
    • 58149340543 scopus 로고    scopus 로고
    • Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer
    • Dowsett M., Dunbier A. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res 2008, 14:8019-8026.
    • (2008) Clin Cancer Res , vol.14 , pp. 8019-8026
    • Dowsett, M.1    Dunbier, A.2
  • 3
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou C., Sorlie T., Eisen M., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
    • (2000) Nature , vol.406 , pp. 747-752
    • Perou, C.1    Sorlie, T.2    Eisen, M.3
  • 4
    • 0042838307 scopus 로고    scopus 로고
    • Breast cancer classification and prognosis based on gene expression profiles from a population-based study
    • Sotiriou C., Neo S., McShane L., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003, 100:10393-10398.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 10393-10398
    • Sotiriou, C.1    Neo, S.2    McShane, L.3
  • 5
    • 33746709476 scopus 로고    scopus 로고
    • Steroid hormone receptor status of mouse mammary stem cells
    • Asselin-Labat M., Shackleton M., Stingl J., et al. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 2006, 98:1011-1014.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1011-1014
    • Asselin-Labat, M.1    Shackleton, M.2    Stingl, J.3
  • 6
    • 34547982817 scopus 로고    scopus 로고
    • Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
    • Tischkowitz M., Brunet J., Begin L., et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer 2007, 7:134-138.
    • (2007) BMC Cancer , vol.7 , pp. 134-138
    • Tischkowitz, M.1    Brunet, J.2    Begin, L.3
  • 7
    • 38049051926 scopus 로고    scopus 로고
    • Immunohistochemical categorisation of ductal carcinoma in situ of the breast
    • Meijnen P., Peterse J., Antonini N., Rutgers E., Van D. Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 2008, 98:137-142.
    • (2008) Br J Cancer , vol.98 , pp. 137-142
    • Meijnen, P.1    Peterse, J.2    Antonini, N.3    Rutgers, E.4    Van, D.5
  • 8
    • 69949125582 scopus 로고    scopus 로고
    • The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast cancer
    • Seung J., Woohee J., Joon J. The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast cancer. Jpn J Clin Oncol 2009, 39(9):560-568.
    • (2009) Jpn J Clin Oncol , vol.39 , Issue.9 , pp. 560-568
    • Seung, J.1    Woohee, J.2    Joon, J.3
  • 9
    • 78651446711 scopus 로고    scopus 로고
    • Expression and clinical significance of androgen receptor in triple negative breast cancer
    • Xiang L., YanXia S., ZhiMing L., WenQi J. Expression and clinical significance of androgen receptor in triple negative breast cancer. Chin J Cancer 2010, 29:123-129.
    • (2010) Chin J Cancer , vol.29 , pp. 123-129
    • Xiang, L.1    YanXia, S.2    ZhiMing, L.3    WenQi, J.4
  • 10
    • 0042071592 scopus 로고    scopus 로고
    • Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies
    • Moinfar F., Okcu M., Tsybrovskyy O., et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 2003, 98:703-711.
    • (2003) Cancer , vol.98 , pp. 703-711
    • Moinfar, F.1    Okcu, M.2    Tsybrovskyy, O.3
  • 11
    • 65249139954 scopus 로고    scopus 로고
    • Mutations and prognosis in breast cancer androgen receptor levels and association with PIK3CA
    • Ana M., Katherine S., Shana L., et al. Mutations and prognosis in breast cancer androgen receptor levels and association with PIK3CA. Clin Cancer Res 2009, 15:2472-2478.
    • (2009) Clin Cancer Res , vol.15 , pp. 2472-2478
    • Ana, M.1    Katherine, S.2    Shana, L.3
  • 12
    • 76349117455 scopus 로고    scopus 로고
    • Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
    • Leo A., David J., Sushil B., Joan M., Rohit B. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol 2010, 23:205-212.
    • (2010) Mod Pathol , vol.23 , pp. 205-212
    • Leo, A.1    David, J.2    Sushil, B.3    Joan, M.4    Rohit, B.5
  • 13
    • 33745603978 scopus 로고    scopus 로고
    • An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
    • Doane A., Danso M., Lal P., et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 2006, 25:3994-4008.
    • (2006) Oncogene , vol.25 , pp. 3994-4008
    • Doane, A.1    Danso, M.2    Lal, P.3
  • 14
    • 44949129660 scopus 로고    scopus 로고
    • Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloprotenases and their inhibitors
    • Gonzalez L., Cortel M., Vazquez J., et al. Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloprotenases and their inhibitors. J BMC Cancer 2008, 8:149-155.
    • (2008) J BMC Cancer , vol.8 , pp. 149-155
    • Gonzalez, L.1    Cortel, M.2    Vazquez, J.3
  • 15
    • 54849414696 scopus 로고    scopus 로고
    • Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
    • Ogawa Y., Hai E., Matsumoto K., et al. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 2008, 13:431-435.
    • (2008) Int J Clin Oncol , vol.13 , pp. 431-435
    • Ogawa, Y.1    Hai, E.2    Matsumoto, K.3
  • 16
    • 77649188673 scopus 로고    scopus 로고
    • Expression of androgen receptors in primary breast cancer
    • Park S., Koo J., Park H., et al. Expression of androgen receptors in primary breast cancer. Ann Oncol 2010, 21:488-492.
    • (2010) Ann Oncol , vol.21 , pp. 488-492
    • Park, S.1    Koo, J.2    Park, H.3
  • 17
    • 0026033066 scopus 로고
    • Staging and follow up of breast cancer patients
    • Kinne D. Staging and follow up of breast cancer patients. Cancer 1991, 67:1196-1198.
    • (1991) Cancer , vol.67 , pp. 1196-1198
    • Kinne, D.1
  • 18
    • 33847147313 scopus 로고    scopus 로고
    • American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolff A., Hammond M., Schwartz J., et al. American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25:118-145.
    • (2007) J Clin Oncol , vol.25 , pp. 118-145
    • Wolff, A.1    Hammond, M.2    Schwartz, J.3
  • 19
    • 0032896905 scopus 로고    scopus 로고
    • Estrogen receptor status by immunohistochemistry is superior to the legend binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    • Harvey J., Clark G., Osborne C., et al. Estrogen receptor status by immunohistochemistry is superior to the legend binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999, 17:1474-1481.
    • (1999) J Clin Oncol , vol.17 , pp. 1474-1481
    • Harvey, J.1    Clark, G.2    Osborne, C.3
  • 20
    • 39549088717 scopus 로고    scopus 로고
    • Androgen receptor as a target for the treatment of hormone receptor negative breast cancer: an unchartered territory
    • Nahleh Z. Androgen receptor as a target for the treatment of hormone receptor negative breast cancer: an unchartered territory. Future Oncol 2008, 4:15-21.
    • (2008) Future Oncol , vol.4 , pp. 15-21
    • Nahleh, Z.1
  • 21
    • 44849106397 scopus 로고    scopus 로고
    • Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast
    • Cho L., Hsu Y. Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast. Kaohsiung J Med Sci 2008, 24:227-232.
    • (2008) Kaohsiung J Med Sci , vol.24 , pp. 227-232
    • Cho, L.1    Hsu, Y.2
  • 22
    • 33744960226 scopus 로고    scopus 로고
    • Race, breast cancer subtypes, and survival in the Carolina breast cancer study
    • Carey L., Perou C., Livasy C., et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 2006, 295:2492-2502.
    • (2006) JAMA , vol.295 , pp. 2492-2502
    • Carey, L.1    Perou, C.2    Livasy, C.3
  • 23
    • 33846266252 scopus 로고    scopus 로고
    • Prognostic markers in triple-negative breast cancer
    • Rakha E.A., Maysa E., et al. Prognostic markers in triple-negative breast cancer. Cancer 2007, 109:25-32.
    • (2007) Cancer , vol.109 , pp. 25-32
    • Rakha, E.A.1    Maysa, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.